Multiple organ failure in a kidney transplant patient receiving both colchicine and cyclosporine

Journal of Nephrology

Volumn 16, Issue 3, 2003, Pages 421-425

  Minetti, Enrico E ^a   Minetti, Luigi ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Colchicine; Cyclosporine A; Drug interaction; Drug toxicity; Kidney transplant; Multiple organ failure

Indexed keywords

ALANINE AMINOTRANSFERASE; ALLOPURINOL; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; COLCHICINE; CREATININE; CYCLOSPORIN; DILTIAZEM; ELECTROLYTE; FUROSEMIDE; GAMMA GLUTAMYLTRANSFERASE; GLYCOPROTEIN P; HEPARIN CALCIUM; INFUSION FLUID; LACTATE DEHYDROGENASE; RAMIPRIL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TICLOPIDINE; VANCOMYCIN;

ABDOMINAL PAIN; ADULT; ARTHRITIS; ARTICLE; ASTHENIA; BLOOD CHEMISTRY; CADAVER KIDNEY; CASE REPORT; CONFUSION; CONSTIPATION; CREATININE BLOOD LEVEL; DIARRHEA; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG INDICATION; DRUG MECHANISM; DRUG POTENTIATION; DRUG TOXICITY; DRUG WITHDRAWAL; FATIGUE; GAIT DISORDER; GOUT; HEART ARRHYTHMIA; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSOMNIA; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; MULTIPLE ORGAN FAILURE; MUSCLE WEAKNESS; NAUSEA; PARALYTIC ILEUS; PARENTERAL NUTRITION; PRESCRIPTION; PROTEINURIA; PSYCHOMOTOR DISORDER; RECIPIENT; RECURRENT DISEASE; RESTLESSNESS; URINE RETENTION;

COLCHICINE; CYCLOSPORINE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MIDDLE AGED; MULTIPLE ORGAN FAILURE;

EID: 0038479929     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ben-Chetrit E, Levy M. Colchicine: 1998 update. Semin Arthritis Rheum 1998; 28: 48-59.
2. Mullins ME, Carrico EA, Horowitz BZ. Fatal cardiovascular collapse following acute colchicine ingestion. J Toxicol Clin Toxicol 2000; 38: 51-4.
3. Folpini A, Furfori P. Colchinine toxicity - Clinical features and treatment. Massive overdose case report. J Toxicol Clin Toxicol 1995; 33: 71-7.
4. Schut NH, Romijn JA. Multi-organ failure caused by colchicine poisoning. Ned Tijdschr Geneeskd 1990; 134: 1508-10.
5. Yussim A, Bar-Nathan N, Lustig S, Shaharabani E, Geier E, Shmuely D, Nakache R, Shapira Z. Gastrointestinal, hepatorenal, and neuromuscular toxicity caused by cyclosporine-colchicine interaction in renal transplantation. Transplant Proc 1994; 26: 2825-6.
6. Kahl LE, Thompson ME, Griffith BP. Gout in the heart transplant recipient: Physiologic puzzle and therapeutic challenge. Am J Med 1989; 87: 289-94.
7. Simkin PA, Gardner GC. Colchicine use in cyclosporine treated transplant recipients: How little is too much? J Rheumatol 2000; 27: 1334-37.
8. Gruberg L, Har-Zahav Y, Agranat O, Freimark D. Acute myopathy induced by colchicine in a cyclosporine treated heart transplant recipient: Possible role of the multidrug resistance transporter. Transplant Proc 1999; 31: 2157-8.
9. Ducloux D, Schuller V, Bresson-Vautrin C, Chalopin JM. Colchicine myopathy in renal transplant recipients on cyclosporin. Nephrol Dial Transplant 1997; 12: 2389-92.
10. Rana SS, Giuliani MJ, Oddis CV, Lacomis D. Acute onset of colchinine myoneuropathy in cardiac transplant recipients: Case studies of three patients. Clin Neurol Neurosurg 1997; 99: 266-70.
11. Lee BI, Shin SJ, Yoon SN, Choi YJ, Yang CW, Bang BK. Acute myopathy induced by colchicine in a cyclosporine-treated renal transplant recipient - A case report and review of the literature. J Korean Med Sci 1997; 12: 160-1.
12. Wluka AE, Ryan PF, Miller AM, Richardson M, Bergin PJ, Page JL, Esmore DS. Post-cardiac transplantation gout: Incidence of therapeutic complications. J Heart Lung Transplant 2000; 19: 951-6.
13. Mochizuki M. Immunotherapy for Behcet's disease. Int Rev Immunol 1997; 14: 49-66.
14. Gueven M, Dogukan A, Cetin M. Colchicine toxicity. Clin Nephrol 1999; 52: 197.
15. DiDiodato G, Sharom FJ. Interaction of combinations of drugs, chemosensitizers, and peptides with the P-glycoprotein multidrug transporter. Biochem Pharmacol 1997; 53: 1789-97.
16. Speeg KV, Maldonado AL. Effect of cyclosporine on colchicine partitioning in the rat liver. Cancer Chemother Pharmacol 1993; 32: 434-6.
17. Sharom FJ, Lu P, Liu P, Ru X. Linear and cyclic peptides as substrates and modulators of P-glycoprotein: Peptide binding and effects on drug transport and accumulation. Biochem J 1998; 333: 621-30.
18. Speeg KV, Maldonado AL, Liaci J, Muirhead D. Effect of cyclosporine on colchicine secretion by the kidney multidrug transporter studied in vivo. J Pharmacol Exp Ther 1992; 261: 50-5.
19. Borron SW, Scherrmann JM, Baud FJ. Markedly altered colchinine kinetics in a fatal intoxication: Examination of contributing factors. Hum Exp Toxicol 1996; 15: 885-90.
20. Cardarelli CO, Aksentijevich I, Pastan I, Gottesman MM. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters. Cancer Res 1995; 55: 1086-91.